ClinicalTrials.gg

Program

ceftobiprole

Also written as “Ceftobiprole” and “pitavastatin single dose combined with ceftobiprole”.

Its studies are mostly in Staphylococcal Skin Infections · Obesity · Pneumonia, Ventilator-Associated, led by Basilea Pharmaceutica.

Furthest: phase 1, since Oct 9, 20088 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Basilea Pharmaceutica80 open or runningphase 1since Oct 9, 2008Oct 9, 2008none ahead

Also a collaborator on its studies: Johnson & Johnson.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 9, 2008First studies: 2 phase 1 studiesFirst studyNCT00771719, NCT00771524
  2. Aug 21, 2009Phase 1 study in Antimicrobial AgentNCT00965042 · 12 enrolled
  3. Dec 3, 20094 phase 1 studiesNCT01026740, NCT01026636, NCT01026558 and 1 more
  4. Jan 9, 2025Phase 1 study in Drug-drug Interaction StudyNCT06808646 · 12 enrolled · Netherlands

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“Bacterial penicillin-binding protein inhibitor”ChEMBL 37, by rule

Studies

All 8 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06808646Drug-drug Interaction Study · Netherlands1CompletedFeb 25, 202512
NCT01030731Staphylococcal Skin Infections1CompletedAug 200712
NCT01026740Staphylococcal Skin Infections1CompletedSep 200715
NCT01026636Staphylococcal Skin Infections1CompletedApr 201064
NCT01026558Obesity1CompletedNov 200725
NCT00965042Antimicrobial Agent1CompletedMay 200912
NCT00771524Total Hip Replacement Surgery1CompletedFeb 201022
NCT00771719Pneumonia, Ventilator-Associated1TerminatedNov 20091

How it is read

Names in the registry

  • “Ceftobiprole”, 7 entries
  • “pitavastatin single dose combined with ceftobiprole”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.